Chlophedianol / guaifenesin / pseudoephedrine Side Effects
Medically reviewed by drugclasses.com. Last updated on Feb 6, 2024.
Applies to chlophedianol / guaifenesin / pseudoephedrine: oral liquid, oral tablet.
Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.
Do not use this medicine if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.
Get emergency medical help if you have any of these signs of an allergic reaction while taking chlophedianol / guaifenesin / pseudoephedrine: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
-
fast, slow, or uneven heart rate;
-
severe dizziness or anxiety, feeling like you might pass out;
-
mood changes, hallucinations;
-
severe headache;
-
tremor, seizure (convulsions);
-
fever; or
-
dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, uneven heartbeats, seizure).
Common side effects may include:
-
mild dizziness or drowsiness;
-
mild headache;
-
diarrhea, constipation, nausea, upset stomach;
-
sleep problems (insomnia); or
-
feeling nervous or restless.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
More about chlophedianol / guaifenesin / pseudoephedrine
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- Drug class: upper respiratory combinations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.